ATXI Tingkat bathi reged Avenue Therapeutics Inc.

A lack of sales and high R&D expenses drive volatility, causing the gross margin growth rate on the GURU.Markets chart to reach 0.00. The fundamentals of Avenue Therapeutics (ATXI) are based on the development of targeted therapies for acute neuropathologies. However, fierce battles over intellectual property rights with industry behemoths increase risks, requiring the company to implement unique medical approaches.
Rincian metrik komprehensif lan analitis Avenue Therapeutics Inc (ATXI)

Avenue Therapeutics specializes in developing innovative drugs for the therapy of rare central nervous system pathologies. Gross margin is calculated as the difference between total revenue and direct production costs, reflecting the efficiency of drug cost management. Analyzing the gross margin structure allows an investor to promptly identify compression in production yields and the risk of capital freeze during a deterioration of the external environment.